Software testing for pharmaceutical systems where compliance protects lives
QAble delivers computer system validation (CSV) and QA services for pharmaceutical software — covering LIMS, ERP, clinical trial management systems, and regulatory submission tools — with 21 CFR Part 11 compliance, GxP validation, and audit trail testing built in.
Testing coverage for:
Engineering teams that rely on QAble
Where pharma software failures trigger regulatory action and patient risk
QAble QA engineers with life sciences domain experience understand the difference between a test that confirms software behaviour and a validation activity that produces GxP evidence. Every engagement produces documentation that holds up under FDA, EMA, or MHRA inspection.
Without pharma QA coverage
21 CFR Part 11 violations in electronic record and signature systems trigger FDA 483 observations and warning letters that halt clinical programmes
Quality RiskLIMS integration failures introduce data integrity gaps between laboratory instruments, sample management, and regulatory reporting — errors that are difficult to detect and costly to remediate
Complianceclinical trial data management system errors corrupt or lose trial data that cannot be recreated — directly impacting the regulatory submission timeline
Process GapGxP-critical software deployed without proper computer system validation (CSV) documentation creates audit exposure that invalidates the data produced by the system
Business Riskaudit trail gaps in manufacturing execution systems create batch record integrity questions that can require product recalls or batch rejection
OperationsThe QAble Solution
Pharma QA is not just about functional correctness — it is about producing the validation evidence that proves to a regulator that the system does what it claims to do.
21 CFR Part 11
electronic record and signature compliance validated
GxP CSV Ready
validation documentation aligned to GAMP 5
Audit Trail
100% data change history completeness validated
Zero Data Gaps
target for LIMS and clinical data integrity tests
Pharma QA coverage areas
QAble covers the full breadth of quality risk across pharma platforms, integrations, and compliance requirements.
21 CFR Part 11 Compliance Testing
Validation of electronic record integrity, audit trail completeness, electronic signature workflows, and access control segregation — producing evidence aligned to FDA 21 CFR Part 11 requirements.
GxP Computer System Validation
CSV services aligned to GAMP 5 — including Installation Qualification (IQ), Operational Qualification (OQ), and Performance Qualification (PQ) — covering category 3, 4, and 5 systems.
LIMS Integration Testing
Testing of integrations between Laboratory Information Management Systems and analytical instruments, sample management platforms, and regulatory reporting systems — validating data transfer accuracy and integrity.
Clinical Trial Data Management
Functional and data integrity testing for CTMS, EDC, and eTMF systems — covering protocol adherence, data entry validation, audit trail integrity, and regulatory submission readiness.
Manufacturing & ERP Testing
Testing of MES, batch record systems, and SAP integrations — covering batch record completeness, equipment logbook accuracy, and the integrity of manufacturing data used in regulatory submissions.
Regulatory Submission Testing
Validation of eCTD, eDMF, and regulatory submission tools — covering document format compliance, metadata accuracy, submission package integrity, and eCTD viewer rendering.
QAble Pharma QA methodology
A disciplined process designed to deliver quality confidence across every pharma release.
Validation Scope & URS Review
Review User Requirement Specification, system classification (GAMP category), and regulatory obligations. Define the validation approach, protocols, and evidence structure before any testing begins.
Validation Plan & Protocol Authoring
Author the Validation Plan, IQ, OQ, and PQ protocols aligned to GAMP 5 and company SOPs. Review and approve with quality stakeholders before execution.
Protocol Execution
Execute IQ, OQ, and PQ protocols with documented test results, deviation capture, and evidence records — every step traceable to the URS and regulatory control requirements.
Deviation & CAPA Management
Document, triage, and resolve all validation deviations with formal CAPA — ensuring the validation evidence package is complete and defensible before sign-off.
Validation Summary Report
Author the Validation Summary Report covering all IQ/OQ/PQ results, deviation closure, residual risk assessment, and GxP release recommendation — ready for quality review and inspector examination.
What you receive
QAble provides structured documentation and evidence your team can act on immediately.
Validation Documentation
Compliance Evidence
Integration & Data Integrity
Continuous Validation Assets
Common Pharma QA risks we identify
These risk patterns recur when pharma platforms lack structured QA coverage.
21 CFR Part 11 Gaps in Audit Trail
Audit trail implementations that do not capture all data changes — or that allow audit records to be modified or deleted — create direct 21 CFR Part 11 violations discoverable during FDA inspection, with potential for warning letters and system quarantine.
System Deployed Without CSV Documentation
GxP-critical systems placed in production without formal validation documentation have no regulatory standing — the data they produce cannot be used in regulatory submissions and the system may need to be retroactively validated or replaced.
LIMS Instrument Integration Errors
Instrument-to-LIMS data transfer errors that produce incorrect values, truncated results, or dropped measurements create data integrity failures that can require batch rejection, investigation, and out-of-specification reporting.
EDC Data Entry Validation Not Tested
Clinical trial EDC systems with insufficient data entry validation rules allow protocol deviations and out-of-range values to be recorded without alerts — creating data quality issues that affect the submission dataset and trial integrity.
Electronic Signature Workflow Incomplete
Electronic signature implementations that do not enforce the signature meaning statement, link signatures to records cryptographically, or restrict second signatory authority create 21 CFR Part 11 non-conformances that require remediation before submission.
Change Control Not Triggering Revalidation
Change control processes that do not systematically assess whether system changes require revalidation result in validated systems operating in an unvalidated state — a gap discoverable during routine inspection.
Ways to work with QAble
From targeted validation sprint engagements to ongoing CSV support for complex pharmaceutical software portfolios — structured around your validation master plan and submission timeline.
1 to 3 weeks
Targeted QA Engagement
Focused quality assurance coverage for a specific release, milestone, or risk area within your product.
Deliverables
Best for
4 to 8 weeks
Full QA Programme
End-to-end quality programme covering functional coverage, integrations, compliance checks, and deliverable documentation.
Deliverables
Best for
Ongoing
Continuous QA Partnership
Embedded QA aligned with your sprint cadence, delivering ongoing coverage, automation, and quality intelligence each release.
Deliverables
Best for
Why choose QAble
QAble brings domain-specific QA methodology built for pharma products: evidence-first, compliance-aware, and release-confident.
QAble Pharma Testing Expertise
Frequently asked questions
Common questions about QAble's pharma testing approach and deliverables.
What is the difference between QA testing and computer system validation (CSV)?
QA testing confirms that software functions correctly. Computer system validation (CSV) produces documented evidence that a GxP-critical system consistently does what it is intended to do — in a form that a regulatory inspector can review. CSV involves formal protocols (IQ, OQ, PQ), executed with witnessed evidence, deviation documentation, and a Validation Summary Report. QAble provides both — functional testing for non-GxP systems and formal CSV services for GxP-critical applications.
Which systems require 21 CFR Part 11 compliance validation?
Any system that creates, modifies, maintains, archives, retrieves, or transmits electronic records that are required to be kept by FDA regulations — including LIMS, EDC, eTMF, manufacturing execution systems, and regulatory submission tools — is subject to 21 CFR Part 11. QAble validates electronic record integrity, audit trail completeness, and electronic signature workflows for each of these system types.
Does QAble produce GAMP 5 aligned validation documentation?
Yes. QAble authors Validation Plans, IQ/OQ/PQ protocols, executed test scripts with evidence, deviation records, and Validation Summary Reports aligned to GAMP 5 and the company's SOPs. Documentation is structured to support regulatory inspection and internal quality review — not formatted to a generic template that does not reflect the specific system and risk profile.
How does QAble handle change control validation support?
For each system change, QAble performs a change control impact assessment against the validated state — determining whether the change requires revalidation and the scope of any revalidation protocols. We author change-specific test protocols, execute them with formal evidence capture, and produce a Change Control Validation Report that closes the change in the validation documentation package.
Validate pharmaceutical software with regulatory-grade evidence, at every release
QAble brings life sciences domain expertise, GAMP 5-aligned CSV documentation, 21 CFR Part 11 compliance testing, and audit-ready evidence production to every pharma engagement.
Pharma QA built for regulatory inspection readiness
QAble covers 21 CFR Part 11 compliance, GxP computer system validation, LIMS and EDC integration testing, clinical data integrity, and regulatory submission QA — with inspection-ready documentation at every milestone.
Talk to QA Advisor
Direct access to QAble's pharma testing specialists.
Response within 24 hours